Aquatic Capital Management LLC Cue Biopharma, Inc. Transaction History

Aquatic Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.23 - $3.37 $14,941 - $22,579	-6,700 Reduced 94.37%	400 $1,000
Q2 2022 Aug 15, 2022	BUY	$2.49 - $5.92 $17,430 - $41,440	7,000 Added 7000.0%	7,100 $18,000
Q1 2022 May 16, 2022	SELL	$4.41 - $12.28 $11,466 - $31,928	-2,600 Reduced 96.3%	100 $0
Q4 2021 Feb 14, 2022	BUY	$10.86 - $17.85 $29,322 - $48,195	2,700 New	2,700 $31,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.